Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
9-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #67
advertisement
Canadian Journal of Ophthalmology
16
Showing records 1 to 16 |
Display all abstracts in
Canadian Journal of Ophthalmology
17985
Self-reported glaucoma in Canada: Findings from population-based surveys, 1994-2003
Perruccio AV; Badley EM; Trope GE
Canadian Journal of Ophthalmology
2007; 42: 219-226
17990
Measurement of anterior lens growth after acute primary angle-closure glaucoma
Yip LW; Aquino MC; Chew PT
Canadian Journal of Ophthalmology
2007; 42: 321-322
17963
Should we treat the brain in glaucoma?
Gupta N; Yücel YH
Canadian Journal of Ophthalmology
2007; 42: 409-413
17973
From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma
Nickells RW
Canadian Journal of Ophthalmology
2007; 42: 278-287
18010
Special considerations in low-tension glaucoma
Krupin T
Canadian Journal of Ophthalmology
2007; 42: 414-417
17983
Sleep-disordered breathing and effects on ocular health
Dhillon S; Shapiro CM; Flanagan J
Canadian Journal of Ophthalmology
2007; 42: 238-243
18078
Is this neuroprotective drug good for my glaucoma patients? Some key factors in clinical decision-making
Goldberg I
Canadian Journal of Ophthalmology
2007; 42: 418-420
18034
Axonal loss and neuroprotection in optic neuropathies
Levin LA
Canadian Journal of Ophthalmology
2007; 42: 403-408
18077
Assessment of the optic disc to measure neuroprotection
Mikelberg FS
Canadian Journal of Ophthalmology
2007; 42: 421-424
18076
Natural compounds: Evidence for a protective role in eye disease
Ritch R
Canadian Journal of Ophthalmology
2007; 42: 425-438
18075
Modulating the immune system: a vaccine for glaucoma?
Schwartz M
Canadian Journal of Ophthalmology
2007; 42: 439-441
17975
Glaucoma neuroprotection: What is it? Why is it needed?
Weinreb RN
Canadian Journal of Ophthalmology
2007; 42: 396-398
18073
Ocular drug delivery: molecules, cells, and genes
Liu X; Brandt CR; Rasmussen CA; Kaufman PL
Canadian Journal of Ophthalmology
2007; 42: 447-454
17986
Comparison of silicone and polypropylene Ahmed glaucoma valves: Two-year follow-up
Mackenzie PJ; Schertzer RM; Isbister CM
Canadian Journal of Ophthalmology
2007; 42: 227-232
17981
Laser treatment to large iris cyst secondary to trabeculectomy
Duan X; Zhang Y; Wang N
Canadian Journal of Ophthalmology
2007; 42: 316-317
18062
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci
Tang CW; Cheng CK; Lee TS
Canadian Journal of Ophthalmology
2007; 42: 477-478
Issue
9-2
Table of Contents
Editor's Selection
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement